{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:21:18Z","timestamp":1791498078873,"version":"4.3.4"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007913","name":"Breast Cancer Now","doi-asserted-by":"publisher","award":["147"],"award-info":[{"award-number":["147"]}],"id":[{"id":"10.13039\/501100007913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C30122\/A11527, C30122\/A15774"],"award-info":[{"award-number":["C30122\/A11527, C30122\/A15774"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L023091\/1"],"award-info":[{"award-number":["MR\/L023091\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["IS-BRC-1215-20006"],"award-info":[{"award-number":["IS-BRC-1215-20006"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01911","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T08:50:47Z","timestamp":1515574247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":121,"title":["Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types"],"prefix":"10.3389","volume":"8","author":[{"given":"Kristina M.","family":"Ilieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Chiaruttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Crescioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merope","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mano","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Tsoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N. J.","family":"Tutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia N.","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ijc.2910280307","article-title":"Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies","volume":"28","author":"Wilson","year":"1981","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14653240902923153","article-title":"Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification","volume":"11","author":"Kozanoglu","year":"2009","journal-title":"Cytotherapy"},{"key":"B3","first-page":"2474","article-title":"Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen","volume":"47","author":"Ziai","year":"1987","journal-title":"Cancer Res"},{"key":"B4","first-page":"1281","article-title":"Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma","volume":"44","author":"Giacomini","year":"1984","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/dvdy.10359","article-title":"Expression of NG2 proteoglycan during endochondral and intramembranous ossification","volume":"228","author":"Fukushi","year":"2003","journal-title":"Dev Dyn"},{"key":"B6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1523-1747.ep12276944","article-title":"Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues","volume":"85","author":"Natali","year":"1985","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/joca.1998.0128","article-title":"Expression of NG2\/human melanoma proteoglycan in human adult articular chondrocytes","volume":"6","author":"Midwood","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"B8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/glia.1063","article-title":"Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion","volume":"34","author":"Bu","year":"2001","journal-title":"Glia"},{"key":"B9","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1523\/JNEUROSCI.22-07-02792.2002","article-title":"NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors","volume":"22","author":"Jones","year":"2002","journal-title":"J Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/micc.12251","article-title":"NG2 proteoglycan-dependent contributions of pericytes and macrophages to brain tumor vascularization and progression","volume":"23","author":"Stallcup","year":"2016","journal-title":"Microcirculation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1242\/dev.002071","article-title":"FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages","volume":"135","author":"Tigges","year":"2008","journal-title":"Development"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1158\/1078-0432.CCR-13-1253","article-title":"Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy","volume":"19","author":"Beard","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.placenta.2013.07.065","article-title":"The chrondroitin sulfate proteoglycan (CSPG4) regulates human trophoblast function","volume":"34","author":"Van Sinderen","year":"2013","journal-title":"Placenta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1091\/mbc.E04-03-0236","article-title":"NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin","volume":"15","author":"Fukushi","year":"2004","journal-title":"Mol Biol Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1001993","DOI":"10.1371\/journal.pbio.1001993","article-title":"Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2","volume":"12","author":"Sakry","year":"2014","journal-title":"PLoS Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1242\/dev.00837","article-title":"Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis","volume":"130","author":"Legg","year":"2003","journal-title":"Development"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s11658-017-0035-3","article-title":"The regulatory mechanisms of NG2\/CSPG4 expression","volume":"22","author":"Ampofo","year":"2017","journal-title":"Cell Mol Biol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9710","DOI":"10.1073\/pnas.93.18.9710","article-title":"Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan","volume":"93","author":"Pluschke","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1083\/jcb.114.2.359","article-title":"The primary structure of NG2, a novel membrane-spanning proteoglycan","volume":"114","author":"Nishiyama","year":"1991","journal-title":"J Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0945-053X(00)00072-X","article-title":"Structure and function of laminin LG modules","volume":"19","author":"Timpl","year":"2000","journal-title":"Matrix Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/BJ20061176","article-title":"Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A)","volume":"403","author":"Iida","year":"2007","journal-title":"Biochem J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1074\/jbc.273.10.5955","article-title":"A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion","volume":"273","author":"Iida","year":"1998","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10769","DOI":"10.1074\/jbc.272.16.10769","article-title":"The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein","volume":"272","author":"Tillet","year":"1997","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jcb.10268","article-title":"NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI","volume":"86","author":"Tillet","year":"2002","journal-title":"J Cell Biochem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M","article-title":"Interaction between NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells is required for optimal response to PDGF","volume":"43","author":"Nishiyama","year":"1996","journal-title":"J Neurosci Res"},{"key":"B26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1242\/jcs.112.6.905","article-title":"PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse","volume":"112","author":"Grako","year":"1999","journal-title":"J Cell Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"18786","DOI":"10.1074\/jbc.M010053200","article-title":"Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen","volume":"276","author":"Iida","year":"2001","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jcb.20768","article-title":"Molecular basis of interaction between NG2 proteoglycan and galectin-3","volume":"98","author":"Wen","year":"2006","journal-title":"J Cell Biochem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.0022-202X.2005.23798.x","article-title":"Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma","volume":"125","author":"Vergilis","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8535","DOI":"10.1038\/ncomms9535","article-title":"Stonin1 mediates endocytosis of the proteoglycan NG2 and regulates focal adhesion dynamics and cell motility","volume":"6","author":"Feutlinske","year":"2015","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G","article-title":"The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2","volume":"79","author":"Barritt","year":"2000","journal-title":"J Cell Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380890-5.00003-X","article-title":"Functional and clinical relevance of chondroitin sulfate proteoglycan 4","volume":"109","author":"Campoli","year":"2010","journal-title":"Adv Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1083\/jcb.200612084","article-title":"Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration","volume":"178","author":"Makagiansar","year":"2007","journal-title":"J Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55262","DOI":"10.1074\/jbc.M411045200","article-title":"Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility","volume":"279","author":"Makagiansar","year":"2004","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200403174","article-title":"Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms","volume":"165","author":"Yang","year":"2004","journal-title":"J Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1755-148X.2011.00929.x","article-title":"CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma","volume":"24","author":"Price","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuroscience.2009.12.014","article-title":"The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination","volume":"166","author":"Kucharova","year":"2010","journal-title":"Neuroscience"},{"key":"B38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.7150\/thno.10824","article-title":"Theranostic impact of NG2\/CSPG4 proteoglycan in cancer","volume":"5","author":"Nicolosi","year":"2015","journal-title":"Theranostics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1089\/ten.tea.2012.0649","article-title":"Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells","volume":"19","author":"Russell","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3892\/ijo.23.2.343","article-title":"Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts","volume":"23","author":"Gazziola","year":"2003","journal-title":"Int J Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nn.3390","article-title":"Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain","volume":"16","author":"Hughes","year":"2013","journal-title":"Nat Neurosci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jor.20694","article-title":"NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients","volume":"27","author":"Benassi","year":"2009","journal-title":"J Orthop Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e23062","DOI":"10.1371\/journal.pone.0023062","article-title":"Targeting the NG2\/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/tpj.2014.40","article-title":"Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer","volume":"15","author":"Volz","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"730170","DOI":"10.1155\/2011\/730170","article-title":"Molecular network associated with MITF in skin melanoma development and progression","volume":"2011","author":"Yajima","year":"2011","journal-title":"J Skin Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"42051","DOI":"10.1074\/jbc.M510590200","article-title":"Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation","volume":"280","author":"Molina","year":"2005","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/onc.2011.425","article-title":"Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells","volume":"31","author":"Cheli","year":"2012","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1189\/jlb.71.2.295","article-title":"The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts","volume":"71","author":"Mansky","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1158\/0008-5472.CAN-08-4626","article-title":"Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12026-011-8232-z","article-title":"The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells","volume":"50","author":"Yu","year":"2011","journal-title":"Immunol Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/glia.22859","article-title":"NG2-glia and their functions in the central nervous system","volume":"63","author":"Dimou","year":"2015","journal-title":"Glia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0002-9440(10)61750-6","article-title":"Glioma classification: a molecular reappraisal","volume":"159","author":"Louis","year":"2001","journal-title":"Am J Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1111\/febs.12109","article-title":"Proteoglycans and their roles in brain cancer","volume":"280","author":"Wade","year":"2013","journal-title":"FEBS J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tranon.2015.12.005","article-title":"The role of NG2 proteoglycan in glioma","volume":"9","author":"Yadavilli","year":"2016","journal-title":"Transl Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/excr.1997.3674","article-title":"A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen","volume":"235","author":"Burg","year":"1997","journal-title":"Exp Cell Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.neuroimage.2005.08.026","article-title":"NG2 expression regulates vascular morphology and function in human brain tumours","volume":"29","author":"Brekke","year":"2006","journal-title":"Neuroimage"},{"key":"B58","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.18632\/oncotarget.3716","article-title":"The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma","volume":"6","author":"Yadavilli","year":"2015","journal-title":"Oncotarget"},{"key":"B59","first-page":"6919","article-title":"Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors","volume":"34","author":"Higgins","year":"2014","journal-title":"Anticancer Res"},{"key":"B60","first-page":"3855","article-title":"Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma","volume":"25","author":"Parker","year":"2005","journal-title":"Anticancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/jnci\/djq343","article-title":"CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer","volume":"102","author":"Wang","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B62","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbrc.2013.10.093","article-title":"High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer","volume":"441","author":"Hsu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/bcr2895","article-title":"Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells","volume":"13","author":"Cooney","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","article-title":"Selectins promote tumor metastasis","volume":"20","author":"Laubli","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/ijc.28906","article-title":"Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients","volume":"135","author":"Warta","year":"2014","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.celrep.2016.06.058","article-title":"Mesenchymal tumors can derive from Ng2\/Cspg4-expressing pericytes with beta-catenin modulating the neoplastic phenotype","volume":"16","author":"Sato","year":"2016","journal-title":"Cell Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/jmcb\/mjt010","article-title":"NG2\/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion","volume":"5","author":"Cattaruzza","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.leu.2401840","article-title":"Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1","volume":"14","author":"Wuchter","year":"2000","journal-title":"Leukemia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.leu.2402989","article-title":"Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)\/CD24(-)\/CD65s(+)\/CD15(+) B-cell phenotype","volume":"17","author":"Schwartz","year":"2003","journal-title":"Leukemia"},{"key":"B70","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood.V89.10.3801.3801_3801_3805","article-title":"MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia","volume":"89","author":"Hilden","year":"1997","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00262-008-0567-5","article-title":"Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies","volume":"58","author":"Drake","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood.V92.1.223.413k15_223_229","article-title":"Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway","volume":"92","author":"Rachmilewitz","year":"1998","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2005.01.005","article-title":"PKC- and PI3K-dependent but ERK-independent proliferation of murine splenic B cells stimulated by chondroitin sulfate B","volume":"99","author":"Aoyama","year":"2005","journal-title":"Immunol Lett"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.0300-9475.2001.01033.x","article-title":"Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity","volume":"55","author":"Yang","year":"2002","journal-title":"Scand J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0165-2478(02)00181-5","article-title":"Effect of chondroitin sulfate on murine splenocytes sensitized with ovalbumin","volume":"84","author":"Sakai","year":"2002","journal-title":"Immunol Lett"},{"key":"B76","doi-asserted-by":"publisher","first-page":"14362","DOI":"10.1073\/pnas.222536599","article-title":"Glycosaminoglycans are a potential cause of rheumatoid arthritis","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1096\/fj.05-4540fje","article-title":"A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration","volume":"20","author":"Rolls","year":"2006","journal-title":"FASEB J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.162.6.1771","article-title":"Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis","volume":"162","author":"MacDermott","year":"1985","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.4161\/cc.8.16.9278","article-title":"New perspectives on APC control of cell fate and proliferation in colorectal cancer","volume":"8","author":"Phelps","year":"2009","journal-title":"Cell Cycle"},{"key":"B80","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1182\/blood.V82.9.2880.2880","article-title":"Proteoglycan metabolism in normal and inflammatory human macrophages","volume":"82","author":"Uhlin-Hansen","year":"1993","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.4049\/jimmunol.178.12.7703","article-title":"Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity","volume":"178","author":"Erfurt","year":"2007","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neuroscience.2009.10.022","article-title":"NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia","volume":"165","author":"Gao","year":"2010","journal-title":"Neuroscience"},{"key":"B83","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF01741341","article-title":"Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen","volume":"34","author":"Ghose","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"B84","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/ijc.20769","article-title":"Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody","volume":"114","author":"Hafner","year":"2005","journal-title":"Int J Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1172\/JCI65579","article-title":"IgG4 subclass antibodies impair antitumor immunity in melanoma","volume":"123","author":"Karagiannis","year":"2013","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1158\/1078-0432.CCR-12-0628","article-title":"CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma","volume":"18","author":"Rivera","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1158\/0008-5472.CAN-10-1134","article-title":"Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.18632\/oncotarget.1291","article-title":"Targeting glioblastoma with NK cells and mAb against NG2\/CSPG4 prolongs animal survival","volume":"4","author":"Poli","year":"2013","journal-title":"Oncotarget"},{"key":"B89","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1615\/CritRevImmunol.v24.i4.40","article-title":"Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance","volume":"24","author":"Campoli","year":"2004","journal-title":"Crit Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/hyb.1.1982.1.423","article-title":"Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens","volume":"1","author":"Harper","year":"1982","journal-title":"Hybridoma"},{"key":"B91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fasebj.9.1.7821758","article-title":"Anti-idiotypic antibodies: biological function and structural studies","volume":"9","author":"Pan","year":"1995","journal-title":"FASEB J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12967-017-1250-4","article-title":"CSPG4: a prototype oncoantigen for translational immunotherapy studies","volume":"15","author":"Rolih","year":"2017","journal-title":"J Transl Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1073\/pnas.89.2.466","article-title":"Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma","volume":"89","author":"Mittelman","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1158\/0008-5472.CAN-04-2328","article-title":"Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s12033-014-9782-9","article-title":"Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigen","volume":"56","author":"Barucca","year":"2014","journal-title":"Mol Biotechnol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI114952","article-title":"Active specific immunotherapy in patients with melanoma. A clinical trial with mouse anti idiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies","volume":"86","author":"Mittelman","year":"1990","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00262-004-0632-7","article-title":"High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells","volume":"54","author":"Riemer","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"B98","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4049\/jimmunol.174.2.976","article-title":"Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro","volume":"174","author":"Wagner","year":"2005","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.4049\/jimmunol.176.10.6046","article-title":"Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects","volume":"176","author":"Luo","year":"2006","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/CJI.0b013e3182307fd8","article-title":"Redirected lysis of human melanoma cells by a MCSP\/CD3-bispecific BiTE antibody that engages patient-derived T cells","volume":"34","author":"Torisu-Itakura","year":"2011","journal-title":"J Immunother"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00262-010-0844-y","article-title":"Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen","volume":"59","author":"Bluemel","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jcyt.2017.06.001","article-title":"Building blocks for institutional preparation of CTL019 delivery","volume":"19","author":"McGuirk","year":"2017","journal-title":"Cytotherapy"},{"key":"B103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2051-1426-2-25","article-title":"Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells","volume":"2","author":"Beard","year":"2014","journal-title":"J Immunother Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-2218","article-title":"T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo","volume":"20","author":"Geldres","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/CJI.0b013e3181ee6675","article-title":"Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b","volume":"33","author":"Craddock","year":"2010","journal-title":"J Immunother"},{"key":"B106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrc3987","article-title":"Radioimmunotherapy of human tumours","volume":"15","author":"Larson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2217\/imt.13.34","article-title":"General overview of radioimmunotherapy of solid tumors","volume":"5","author":"Navarro-Teulon","year":"2013","journal-title":"Immunotherapy"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2217\/imt.11.97","article-title":"Analysis of patient survival in a phase I trial of systemic targeted alpha-therapy for metastatic melanoma","volume":"3","author":"Allen","year":"2011","journal-title":"Immunotherapy"},{"key":"B109","first-page":"114","article-title":"Targeted radioimmunotherapy of triple negative breast cancer with CSPG4-specific 212Pb-labeled monoclonal antibody","volume":"57","author":"Kasten","year":"2016","journal-title":"J Nuc Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"E532","DOI":"10.1208\/aapsj080363","article-title":"Immunotoxins for targeted cancer therapy","volume":"8","author":"Kreitman","year":"2006","journal-title":"AAPS J"},{"key":"B111","doi-asserted-by":"publisher","first-page":"pii: E36","DOI":"10.3390\/biomedicines5030036","article-title":"Human MAP Tau based targeted cytolytic fusion proteins","volume":"5","author":"Akinrinmade","year":"2017","journal-title":"Biomedicines"},{"key":"B112","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ijc.30119","article-title":"A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein","volume":"139","author":"Amoury","year":"2016","journal-title":"Int J Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"pii: E37","DOI":"10.3390\/biomedicines5030037","article-title":"CSPG4: a target for selective delivery of human cytolytic fusion proteins and TRAIL","volume":"5","author":"Jordaan","year":"2017","journal-title":"Biomedicines"},{"key":"B114","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1476-4598-9-301","article-title":"Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo","volume":"9","author":"de Bruyn","year":"2010","journal-title":"Mol Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1535-7163.MCT-14-0290","article-title":"Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma","volume":"13","author":"Ilieva","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"78174","DOI":"10.18632\/oncotarget.19836","article-title":"BRAF inhibitors: resistance and the promise of combination treatments for melanoma","volume":"8","author":"Griffin","year":"2017","journal-title":"Oncotarget"},{"key":"B117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3892\/ijo.2015.3010","article-title":"Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia","volume":"47","author":"Pucciarelli","year":"2015","journal-title":"Int J Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"54925","DOI":"10.18632\/oncotarget.10705","article-title":"Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand","volume":"7","author":"Amoury","year":"2016","journal-title":"Oncotarget"},{"key":"B119","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-09-2824","article-title":"A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas","volume":"70","author":"Burns","year":"2010","journal-title":"Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jconrel.2016.01.052","article-title":"The application of local hypobaric pressure \u2013 a novel means to enhance macromolecule entry into the skin","volume":"226","author":"Inacio","year":"2016","journal-title":"J Control Release"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01911\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T14:52:50Z","timestamp":1693407170000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01911\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":120,"alternative-id":["10.3389\/fimmu.2017.01911"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01911","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"article-number":"1911"}}